Bessemer: Anthropic Has Been Consistent on AI Safety

Anthropic Unveils Cheaper Claude Opus 5.5 Ahead of Expected IPO

Bessemer Raises $5.75 Billion in New Funds, Expands Growth Efforts

Novo Nordisk Will Use Anthropic’s Claude for Drug Research